Cite
HARVARD Citation
Gao, N. et al. (2022). Role of hepatitis B surface antibody in seroreversion of hepatitis B surface antigen in patients achieving hepatitis B surface antigen loss with pegylated interferon‐based therapy. Journal of viral hepatitis. 29 (10), pp. 899-907. [Online].